# Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia

> **NCT05899842** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 132 (estimated)

## Conditions studied

- Esophageal Achalasia

## Interventions

- **DRUG:** Protein pump inhibitor therapy systematically

## Key facts

- **NCT ID:** NCT05899842
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05899842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05899842, "Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05899842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*